Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB

NCT00204529 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

901

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: pegylated interferon-alpha-2a
DRUG: interferon-alpha-2a

Sponsor

University Hospital Tuebingen

Collaborators

[object Object]